These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 23574937

  • 41. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC, Nicholson HD, Gold EJ.
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [Abstract] [Full Text] [Related]

  • 42. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E, Berger A, Melne V, Bajo-Santos C, Soboļevska K, Ābols A, Rodriguez M, Šantare D, Rudņickiha A, Lietuvietis V, Llorente A, Linē A.
    BMC Cancer; 2017 Nov 09; 17(1):730. PubMed ID: 29121858
    [Abstract] [Full Text] [Related]

  • 43. Circulating microRNAs in plasma before and after radical prostatectomy.
    McDonald AC, Raman JD, Shen J, Liao J, Pandya B, Vira MA.
    Urol Oncol; 2019 Nov 09; 37(11):814.e1-814.e7. PubMed ID: 31421994
    [Abstract] [Full Text] [Related]

  • 44. Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.
    Goto Y, Kurozumi A, Arai T, Nohata N, Kojima S, Okato A, Kato M, Yamazaki K, Ishida Y, Naya Y, Ichikawa T, Seki N.
    Br J Cancer; 2017 Jul 25; 117(3):409-420. PubMed ID: 28641312
    [Abstract] [Full Text] [Related]

  • 45. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, Peng H, Pu Y, Yin L, Liang G.
    Oncol Rep; 2017 Jun 25; 37(6):3543-3553. PubMed ID: 28498428
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Role of MicroRNA-21 in Prostate Cancer Progression and Metastasis: Molecular Mechanisms to Therapeutic Targets.
    Singh VK, Rajak N, Singh Y, Singh AK, Giri R, Garg N.
    Ann Surg Oncol; 2024 Jul 25; 31(7):4795-4808. PubMed ID: 38758485
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
    Zidan HE, Abdul-Maksoud RS, Elsayed WSH, Desoky EAM.
    IUBMB Life; 2018 May 25; 70(5):437-444. PubMed ID: 29522280
    [Abstract] [Full Text] [Related]

  • 50. Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer.
    Roberts MJ, Chow CW, Schirra HJ, Richards R, Buck M, Selth LA, Doi SA, Samaratunga H, Perry-Keene J, Payton D, Yaxley J, Lavin MF, Gardiner RA.
    Prostate; 2015 Apr 01; 75(5):539-49. PubMed ID: 25597828
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide.
    Seitz AK, Thoene S, Bietenbeck A, Nawroth R, Tauber R, Thalgott M, Schmid S, Secci R, Retz M, Gschwend JE, Ruland J, Winter C, Heck MM.
    Eur Urol; 2017 Nov 01; 72(5):828-834. PubMed ID: 28818355
    [Abstract] [Full Text] [Related]

  • 53. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P, Tanriverdi K, Curran C, Gilligan K, Freedman JE, Brown JAL, Kerin MJ.
    BMC Cancer; 2019 May 10; 19(1):436. PubMed ID: 31077182
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer.
    Matin F, Jeet V, Moya L, Selth LA, Chambers S, Australian Prostate Cancer BioResource, Clements JA, Batra J.
    Sci Rep; 2018 Apr 27; 8(1):6653. PubMed ID: 29703916
    [Abstract] [Full Text] [Related]

  • 57. Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.
    Xia L, Han Q, Chi C, Zhu Y, Pan J, Dong B, Huang Y, Xia W, Xue W, Sha J.
    Biomed Pharmacother; 2020 Apr 27; 124():109863. PubMed ID: 31986411
    [Abstract] [Full Text] [Related]

  • 58. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
    Toiyama Y, Hur K, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A.
    Ann Surg; 2014 Apr 27; 259(4):735-43. PubMed ID: 23982750
    [Abstract] [Full Text] [Related]

  • 59. MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214.
    Srivastava A, Goldberger H, Dimtchev A, Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen LN, Li X, Berry DL, Kallakury BV, Chauhan SC, Collins SP, Suy S, Kumar D.
    PLoS One; 2013 Apr 27; 8(10):e76994. PubMed ID: 24167554
    [Abstract] [Full Text] [Related]

  • 60. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
    Zhao S, Yao D, Chen J, Ding N.
    Genet Test Mol Biomarkers; 2013 Aug 27; 17(8):631-6. PubMed ID: 23819812
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.